nirogacestat,lenalidomide,teclistamab,daratumumab,pomalidomide,bortezomib
takeda,springworks therapeutics,janssen,genmab,bms
['majestec-2', 'lenalidomide', 'teclistamab', ' lena', 'majestec,(-majestec-1),(-majestec1),(-majestec 1),(-majestec-3),(-majestec3),(-majestec 3),(-majestec-i),(-majestec i),(-majesteci)']
results from the majestec-2 trial shows high efficacy of teclistamab in combination with dararumumab plus lenalidomide in heavily pretreated #myeloma, as presented ata #ash22 #ash2022 meeting 